Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

BACKGROUND: Current standard of treatment for newly diagnosed patients with glioblastoma (GBM) is surgical resection with adjuvant normofractionated radiotherapy (NFRT) combined with temozolomide (TMZ) chemotherapy. Hyperfractionated accelerated radiotherapy (HFRT) which was known as an option from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewitzki, Victor, Klement, Rainer J., Kosmala, Rebekka, Lisowski, Dominik, Flentje, Michael, Polat, Bülent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909505/
https://www.ncbi.nlm.nih.gov/pubmed/31831026
http://dx.doi.org/10.1186/s13014-019-1427-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909505/
https://www.ncbi.nlm.nih.gov/pubmed/31831026
http://dx.doi.org/10.1186/s13014-019-1427-5

Ejemplares similares